Literature DB >> 1426388

The comparison of two gonadotropin-releasing hormone agonists in an in vitro fertilization program.

J Balasch1, I C Jové, V Moreno, S Civico, B Puerto, J A Vanrell.   

Abstract

OBJECTIVE: To compare two gonadotropin-releasing hormone agonists (GnRH-a), buserelin acetate and leuprolide acetate [LA], used in combination with gonadotropins in ovarian stimulation for in vitro fertilization (IVF).
DESIGN: Randomized prospective study.
SETTING: Assisted Reproduction Unit of the Hospital Clínic i Provincial in Barcelona. PATIENTS: Thirty-five pairs of IVF patients who were matched on age, indication, and number of attempts. These women were randomized to receive either buserelin acetate plus gonadotropins (group B) or LA plus gonadotropins (group L). MAIN OUTCOME MEASURES: Luteolysis, ovarian response, and IVF outcome.
RESULTS: The mean time for total ovarian arrest and the total dose of gonadotropins and estradiol levels on the day of human chorionic gonadotropin administration were similar in the two groups of patients. The number of follicles punctured, the number of oocytes retrieved, and the percentage of mature oocytes in group L were significantly higher. The number of embryos suitable for replacement and cryopreservation was higher in group L compared with group B approaching statistical significance.
CONCLUSION: Our results warrant further studies to compare different GnRH-a as therapeutic tools in IVF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426388     DOI: 10.1016/s0015-0282(16)55448-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

Review 1.  Treatment of polycystic ovary patients undergoing IVF.

Authors:  P N Barri; B Coroleu; F Martinez; J M Traver; A Veiga; G Calderon
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

2.  Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome.

Authors:  F Fábregues; J Balasch; M Creus; F Carmona; B Puerto; L Quintó; R Casamitjana; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

3.  Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques.

Authors:  B C Tarlatzis; G Grimbizis; F Pournaropoulos; J Bontis; S Lagos; G Pados; S Mantalenakis
Journal:  J Assist Reprod Genet       Date:  1994-02       Impact factor: 3.412

4.  Comparison between depot leuprorelin and daily buserelin in IVF.

Authors:  E Porcu; M Filicori; L Dal Prato; R Fabbri; R Seracchioli; C Colombi; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

Review 5.  Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.

Authors:  G L Plosker; R N Brogden
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

6.  Significance of an abnormal response during pituitary desensitization in an in vitro fertilization and embryo transfer program.

Authors:  S K Goswami; B N Chakravarty; S N Kabir
Journal:  J Assist Reprod Genet       Date:  1996-05       Impact factor: 3.412

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.